NextCure Correlations

NXTC Stock  USD 13.21  0.11  0.84%   
The current 90-days correlation between NextCure and Q32 Bio is -0.04 (i.e., Good diversification). The correlation of NextCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

NextCure Correlation With Market

Weak diversification

The correlation between NextCure and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.

Moving against NextCure Stock

  0.54VANI Vivani MedicalPairCorr
  0.48ALSEN Sensorion SAPairCorr
  0.43JUMP Leveljump Healthcare CorpPairCorr
  0.39OB3 OPTIBIOTIX HLTH PLCPairCorr
  0.33H2K2 XTL Biopharmaceuticals SplitPairCorr
  0.4775J LEVELJUMP HEALTHCAREPairCorr
  0.46CDTTW Conduit PharmaceuticalsPairCorr
  0.44VINC Vincerx Pharma CommonPairCorr
  0.41DTIL Precision BioSciencesPairCorr
  0.39IGS1 India GlobalizationPairCorr
  0.34VTGN VistaGen TherapeuticsPairCorr
  0.329OF BIORESTORATTHERAPDLPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ITRMTAOX
JSPRPSTV
ANTXBOLD
ITRMINTS
ITRMPSTV
INTSPSTV
  

High negative correlations

PLURVRCA
TAOXQTTB
ITRMQTTB
PSTVQTTB
JSPRQTTB
PLURQTTB

Risk-Adjusted Indicators

There is a big difference between NextCure Stock performing well and NextCure Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NextCure's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
QTTB  5.10  1.22  0.20 (2.15) 4.68 
 9.17 
 85.16 
PSTV  4.94 (0.91) 0.00 (0.29) 0.00 
 9.43 
 48.30 
BOLD  2.08 (0.12) 0.00 (0.33) 0.00 
 4.24 
 16.75 
VRCA  5.37  0.82  0.15  0.37  5.18 
 13.76 
 52.65 
ANTX  2.48 (0.16) 0.00 (0.24) 0.00 
 4.55 
 32.31 
JSPR  4.05 (0.40) 0.00 (1.02) 0.00 
 7.19 
 31.75 
INTS  4.96 (0.65) 0.00 (0.23) 0.00 
 11.43 
 63.20 
PLUR  3.72 (0.05) 0.00  0.82  0.00 
 9.90 
 22.62 
TAOX  5.49 (0.94) 0.00 (0.19) 0.00 
 11.74 
 33.82 
ITRM  4.74 (1.20) 0.00 (0.42) 0.00 
 9.38 
 26.92 

NextCure Corporate Management

CPA CPAChief OfficerProfile
Steven CPAChief OfficerProfile
Sebastien MalovesteSenior DevelopmentProfile
Sourav KunduSenior ManufacturingProfile
Kevin ShawGeneral CounselProfile
Michael MSBACEO, CoFounderProfile
Lieping MDCoFounder BoardProfile